PRL and schizophrenia: This post-hoc analysis examined the effect of aripiprazole on prolactin levels in patients with schizophrenia in a real-life diagnostic environment, and analyzed whether varying baseline prolactin levels influence the effectiveness and safety of aripiprazole.